Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models

scientific article published in PLoS ONE

Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2014PLoSO...995549.
P356DOI10.1371/JOURNAL.PONE.0095549
P932PMC publication ID3989332
P698PubMed publication ID24740287

P2093author name stringBruce E Kemp
Nirma D Perera
Rebecca K Sheean
Malcolm K Horne
John W Scott
Bradley J Turner
P2860cites workMutant TDP-43 deregulates AMPK activation by PP2A in ALS models.Q35111080
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectamyotrophic lateral sclerosisQ206901
P304page(s)e95549
P577publication date2014-01-01
P1433published inPLOS OneQ564954
P1476titleMutant TDP-43 deregulates AMPK activation by PP2A in ALS models
P478volume9

Reverse relations

cites work (P2860)
Q38998405AMPK in Neurodegenerative Diseases
Q39123368Cysteine Modifications in the Pathogenesis of ALS.
Q40760240Early ALS-type gait abnormalities in AMP-dependent protein kinase-deficient mice suggest a role for this metabolic sensor in early stages of the disease
Q55282282Exploring microRNA Biomarker for Amyotrophic Lateral Sclerosis.
Q39101800Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments
Q41429779Mitochondrial quality control in amyotrophic lateral sclerosis: towards a common pathway?
Q47130471Targeting PP2A activates AMPK signaling to inhibit colorectal cancer cells